many in Biological Technology

Hepatitis C Virus Patient Opportunity Exists Within Many of the Major U.S. Local Markets

However, Insurance Coverage of Hepatitis C Patients Is Skewed Towards Medicare and Medicaid Compared With Dominance of Private Coverage in the General Population, According to a New Analytics Tool From Decision Resources WALTHAM, Mass., Feb. 12 /PRNewswire/ -- Decision Resources, one of the w...

Ultrasound Transducer Disinfection in Many Cases Insufficient

HAMBURG, Germany, December 11 /PRNewswire/ -- - New 'Trophon EPR' Device Offers Unique Solution Current methods of ultrasound transducer disinfection are in many cases not sufficient for clinical practice. This is the latest alarming result issued by the Center for Disease Control ...

New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD

- More than one quarter (26%) of primary care patients 40 years of age and older with a smoking history and symptoms of chronic bronchitis had airflow obstruction consistent with a diagnosis of COPD - Percentages were greater with increasing patient age and smoking history PHILADELP...

Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers'

- 60 percent say they are not risk takers with their health, yet up to one-third of those skip critical health screenings - 42 percent are at elevated risk for cardiovascular events, yet 20 percent of those have not spoken with their physician about preventive benefits of ...

Foldable and stretchable, silicon circuits conform to many shapes

CHAMPAIGN, Ill. Scientists have developed a new form of stretchable silicon integrated circuit that can wrap around complex shapes such as spheres, body parts and aircraft wings, and can operate during stretching, compressing, folding and other types of extreme mechanical deformations, without a ...

The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis

WORCESTER, Massachusetts, February 1 /PRNewswire/ -- - ENDORSE Global Findings Highlight the Need to Urgently Implement Hospital-Wide Strategies to Optimize VTE Management: Systematically Assess Patient Risk for VTE and Provide Appropriate Prophylaxis to Prevent VTE ENDORSE multinational s...

Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges

- Affordable, Easy-to-Use Accessible Technology is Within Reach for People with MS - DALLAS, Oct. 26 /PRNewswire/ -- According to a new survey released this week in conjunction with the National MS Society's National Conference, many people living with multiple scl...

Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006

2007 Winners Demonstrate Strong Correlation Between Citations and Professional Awards PHILADELPHIA, and LONDON, Oct. 16 /PRNewswire-FirstCall/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC ; TSX: TOC) and leading provider of information solution...

European Union has 'Three-Speed' Healthcare System - Many Countries Lagging in Reform

BRUSSELS, October 1 /PRNewswire/ -- Austria now has the most consumer-friendly healthcare system in Europe, according to the 2007 Euro Health Consumer Index (EHCI). The EHCI compares all the EU 27 national healthcare systems, along with Norway and Switzerland, from a consumer-friendly point of...

New Survey Reveals Many Adults With High Cholesterol Fail to Take Necessary Steps to Improve Their Condition

'Significant Disconnect' Exists Between Understanding Cholesterol Monitoring Versus Implementing Changes to Lower Cholesterol Levels PARSIPPANY, N.J., Sept. 4, 2007 /PRNewswire/ -- A recent survey of U.S. adults with high cholesterol* shows that in spite of concerns about the serious heal...

Hurricane Katrina: Many disaster recovery systems were outdated

Despite predictions and preventative measures, Katrina caught many businesses and people off guard. Asks adjunct Northwestern professor James Carlini, what disaster recovery plans do you really have in place for your business and your home and how updated are they? While most of the news covera...

IT critical in pandemic response, but many are not paying attention

Scientists say it's not a matter of if, but when. And when pandemic flu hits an event that could, at the least, keep large sections of the population from working, shut down travel and public institutions and cause infrastructure outages information technology may be called on to ease the burden ...

Bioscience clusters: Too many or room for more?

Ten months after the BIO 2006 International Conference in Chicago, the Illinois Biotech Industry Organization (IBIO) held its own annual event. After all the excitement and energy coming from 20,000 attendees and visitors coming from 62 countries last April, the IBIO meeting was quiet in compar...

Growth spurts

...sses behind those products by ensemble averages of many molecules. The limitations of that approach have b...tals are so dependent upon size and shape that for many applications it is critical that monodispersed nan...talysis, and offers great potential for addressing many fundamental issues in materials science, chemistry...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...rm 8-K filed with the SEC on February 26, 2009 and the Company's Form 8-K filed with the SEC on February 30, 2009; (25) delays in returning certain or many of the Company's products to market, including loss of market share as a result of the suspension of shipments, and related costs; (26) sale or licens...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

...e additional resources for us to develop our Controlled Delivery Technology (CDT(R)) platforms. However, we are faced with a difficult marketplace and many specialty pharmaceutical companies competing for alliances with the more established pharmaceutical and consumer product companies. Our operating stra...

Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product

...l procedures. The Company provides an extensive range of products into multiple medical markets, including sports medicine, spine, and endovascular. many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, ...

Viral Genetics Creates Subsidiary to Develop Cancer Therapy

...or proof of principal--either in vitro or in animal models. Dr. Newell, who has been on the cutting edge of metabolic disruption of tumor cells for many years helped develop the process for Viral Genetics. "The results are consistently supportive that metabolic disruption, in combination with c...

ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA

...s detection of both high-molecular-weight (HMW) and total adiponectin. The human multimeric adiponectin ELISA from ALPCO and Sekisui has been cited in many publications, and is trusted by the research community worldwide for its consistency and quality. The new mouse HMW and total adiponectin ELISA has be...

Microbix Sales Grow 22% For Nine Months

...mpanies in the animal health field or livestock industries is attractive to many commercial players. The Microbix technology has the potential to provide a ...s currently evaluating all options for the inventory." Microbix is one of many drug companies that are experiencing delays at the FDA today and continues ...

Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer

...rowth and his contribution at such a critical juncture will be welcome by everyone on our Executive Team. We are looking forward to tapping into his many years of biotechnology industry experience as we expand our vaccine development programs, manufacturing operations and international collaborations." ...

SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights

...gan published promising results in the use of the AttoSense(TM) HPV test in the Journal of Virological Methods. Results from this study showed that as many as 15% of women in the study group determined to be negative for the presence of human papillomavirus (HPV) in the cervix, via the most commonly used ...

Transposagen Creates a Rat Model of the Human Immune System

...ial therapeutic compounds. This is partially because the number and type of many of the rat's detoxifying enzymes are very similar to those in humans. Rats ...categories including human cardiovascular disease, diabetes, arthritis, and many autoimmune, neurological and behavioral disorders. Transposagen ha...

PharmatrophiX, Initially Funded by the Alzheimer's Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan

...y and shows great promise in preventing and treating this terrible disease," says Dr. Fillit. "And this all started with an idea from Frank Longo that many thought was a little improbable. But ADDF is able to take chances on high-risk ideas - we know that this is often where the best solutions come from."...

Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009

...ts or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. many such known risks, uncertainties and other factors are taken into account as part of our assumptions underlying these forward-looking statements and in...

New clues about a hydrogen fuel catalyst

...catalyst chemically reacts with ammonia borane, a molecule that stores hydrogen densely, to release the hydrogen as a gas. Their results, which reveal many molecular details of this catalytic reaction, appear August 5 in the Journal of the American Chemical Society . "These studies tell us what is th...

Exciton Technologies receives FDA approval to market exSALT(TM)

...silver. The Company's technologies offer next-generation, less expensive and environmentally friendly products, enabling the company to participate in many industries, including the wound care and disinfectant markets. Forward-looking Statements -------------------------- This press relea...

PDI Reports 2009 Second Quarter Financial Results

..., future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond PDI's control. These statements also involve known and unknown risks, uncertainties and other factors that may cause PDI's actual...

AIAG and MichBio Form New Collaborative Partnership

...or medical care from patients, and advances in medical technologies. While many synergies exist, some retooling will most likely be required. However, medi... Company, General Motors, Honda, Navistar International, Nissan, Toyota and many of their part suppliers and service providers. For more information, please...

GeoVax Labs, Inc. Provides Clinical Studies Update

...imulate both anti-HIV T cell and anti-HIV antibody immune responses. Stimulation of both T cells and antibodies differentiates the GeoVax vaccine from many other vaccine candidates. GeoVax's DNA and MVA vaccines are used in a prime-boost protocol in which priming is done with the DNA and boosting with th...

BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial Proven To Be Completely Inert to Steel In Independent Corrosion Testing

...de Antimicrobial was found to be completely non-corrosive to steel. many of today's commercially available antimicrobials and cleaners are corrosive..." said Stephen J. Browand BioNeutral Group's CEO. "Commercially, there are many circumstances where a green, inert, sporicidal antimicrobial will be prefer...

NxStage Reports Second Quarter 2009 Financial Results

...rnational sales, and other expectations as to future operating results. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond NxStage's control, which may cause actual results, performance, or achievements to differ materially from anticipated results, per...

Next Safety Releases Advanced Respirator for Infectious Diseases

... Next Safety is a leader in the development of pulmonary health products. It has a product line of advanced respirators that were developed for many different applications. The company also develops pulmonary drug delivery products. It is a leader in the development of nicotine delivery de...

Saint-Gobain Introduces Next Generation Silicone Tubing

...ce in a number of areas. Fluid integrity is of crucial importance in many biopharmaceutical operations. Sani-Tech(R) Ultra formulations are manufactu...maceutical industry. Tygon(R), C-Flex(R) and Pure-Fit are just a few of the many well-known brands in the company's portfolio. About Saint-Gobain Pe...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

...sources to continue its groundbreaking research in many promising areas such as cell processing, imaging s...in evaluating potential therapeutic treatments for many critical health challenges facing the U.S. and the...ts are subject to various risks and uncertainties, many of which are difficult to predict and generally be...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia

...covery engine capitalizes on its proprietary high-resolution crystal structure of the ribosome, which performs an essential role in protein synthesis. many known, commercially valuable antibiotics exert their effects by binding to the bacterial ribosome. The Company's integrated research strategy, which c...

Pharmacy Compounds Liquid Mupirocin for the Chronic Sinusitis Patient

...And because this sterile compound is prepared in pre-mixed unit dosed vials, it may easily be used for sinus irrigation or sinus nebulization. ASL and many prescribing physicians find this treatment to be well tolerated among patients, producing excellent results. Physicians may call ASL Pharmacy® a...

Micromet Closes $80.5 Million Public Offering of Common Stock

...nical trial for the treatment of patients with solid tumors. MT110 binds to the epithelial cell adhesion molecule, or EpCAM, which is overexpressed in many solid tumors. Micromet's human monoclonal antibody adecatumumab (MT201) also binds to EpCAM and is being developed under a collaboration with Merck Se...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...charine. Regulatory-focused development activities for promising bitter blockers are underway. "Reducing bitterness would be valuable for the many manufacturers who want to improve the taste characteristics of food, beverage, healthcare, and other products," Snyder stated. "We are encouraged by ...

Oncothyreon appoints Diana Hausman as Vice President of Clinical Development

... statements involve risks and uncertainties, including risks and uncertainties related to Oncothyreon's business and the general economic environment. many of these risks and uncertainties are beyond Oncothyreon's control. These risks, uncertainties and other factors could cause our actual results to diff...